Gateway Wealth Partners LLC grew its stake in Amplify Seymour Cannabis ETF (NYSEARCA:CNBS – Free Report) by 3.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 126,522 shares of the company’s stock after purchasing an additional 4,084 shares during the period. Gateway Wealth Partners LLC’s holdings in Amplify Seymour Cannabis ETF were worth $568,000 at the end of the most recent reporting period.
Separately, Wealth Alliance acquired a new position in shares of Amplify Seymour Cannabis ETF in the second quarter valued at approximately $89,000.
Amplify Seymour Cannabis ETF Price Performance
NYSEARCA:CNBS opened at $4.60 on Tuesday. The stock’s 50 day simple moving average is $4.38 and its 200-day simple moving average is $4.69. Amplify Seymour Cannabis ETF has a 12-month low of $3.38 and a 12-month high of $6.48.
Amplify Seymour Cannabis ETF Profile
The Amplify Growth Opportunities ETF (CNBS) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of global stocks related to cannabis and hemp. The fund also invests in derivatives with similar characteristics. CNBS was launched on Jul 23, 2019 and is managed by Amplify.
Read More
- Five stocks we like better than Amplify Seymour Cannabis ETF
- Investing in the High PE Growth Stocks
- 2 Stocks That Crushed Short Sellers With Impressive Gains
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 Global Semiconductor Stocks Set to Benefit From China’s EV Boom
- Why is the Ex-Dividend Date Significant to Investors?
- Inflation Trades Gain Momentum: What Investors Should Watch
Want to see what other hedge funds are holding CNBS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amplify Seymour Cannabis ETF (NYSEARCA:CNBS – Free Report).
Receive News & Ratings for Amplify Seymour Cannabis ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amplify Seymour Cannabis ETF and related companies with MarketBeat.com's FREE daily email newsletter.